Intraoperative Cone-beam CT for Percutaneous Nephrolithotomy

Sponsor
Loyola University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT04556396
Collaborator
(none)
67
1
2
17.2
3.9

Study Details

Study Description

Brief Summary

Percutaneous nephrolithotomy (PCNL) is a first-line treatment for kidney stones >2cm. Frequently, patients require multiple procedures to address their stone burden. The decision to proceed with a second-look procedure is based on follow-up CT imaging, which is obtained postoperatively. In this study, we propose the use of a portable CT scan technology to obtain follow-up imaging while the patient is still under anesthesia for the initial procedure. The goal of this study is to determine whether this allows the surgeon to identify residual fragments and render the patient stone-free within a single anesthetic event.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Cone beam CT
N/A

Detailed Description

Percutaneous nephrolithotomy (PCNL) is considered a first-line management option for kidney stones larger than two centimeters. Unfortunately, because of the large stone burden, up to 70% of these patients are left with residual stone fragments after their initial PCNL. Additionally, an estimated 20% to 60% of such patients ultimately require further interventions due to residual stone fragments. The need for a subsequent procedure is determined by postoperative abdominal computed tomography (CT) imaging, which is routinely performed on the first postoperative day at this institution. The decision to proceed with a second procedure is based on findings from this postoperative CT scan.

Cone-beam CT (CBCT) is a novel portable imaging technique that can allow cross-sectional imaging to be obtained intraoperatively, rather than post-operatively. Incorporating this modality would allow the surgeon to determine whether the procedure should be continued, in the event of residual fragments, or if it can be safely concluded. This would obviate the need for dedicated postoperative CT scans and, more importantly, reduce the need for subsequent procedures and consequently decrease the patient's length of stay.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
67 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Intervention Model Description:
Patients are assigned to receive intraoperative cone beam CT if enrolled.Patients are assigned to receive intraoperative cone beam CT if enrolled.
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Intraoperative Cone-beam CT for Percutaneous Nephrolithotomy
Actual Study Start Date :
Jun 25, 2020
Actual Primary Completion Date :
Jul 1, 2021
Anticipated Study Completion Date :
Dec 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention arm

This arm will receive cone beam CT to perform an abdomen-pelvis CT scan immediately following initial percutaneous nephrolithotomy, before the patient emerges from general anesthesia, to allow the surgeon to determine whether additional work is needed or whether the procedure can be concluded without requiring further imaging or future interventions.

Diagnostic Test: Cone beam CT
On-table CT scan in the operating room to determine residual kidney stone burden at end of procedure
Other Names:
  • O-arm
  • Intraoperative CT
  • No Intervention: Retrospective arm

    This arm will contain a retrospective cohort of patients who underwent surgery prior to the enrollment of the intervention arm. These patients received the standard of care, namely helical CT postoperative day one.

    Outcome Measures

    Primary Outcome Measures

    1. "Second Look" rate [90 days]

      The percentage of patients requiring subsequent surgical intervention to remove residual stones

    Secondary Outcome Measures

    1. Hospital length of stay [90 days]

      The average length of inpatient hospital stay in days

    2. Surgical complication rate [90 days]

      The percentage of patients experiencing Clavien-Dindo Grade III-V complications related to the patients' surgery

    3. "Stone Free" rate [90 days]

      The percentage of patients who are rendered without residual kidney stone burden after their surgery based on CT scan

    4. Reobstruction rate [90 days]

      The percentage of patients who presented with symptoms of renal obstruction following their surgery

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Patients >18 years old

    2. Scheduled for percutaneous nephrolithotomy with stone fragmentation (laser/ultrasonic/mechanical)

    3. For the prospective intervention arm, willingness to consent to participate in the study

    Exclusion Criteria:
    1. Patients whose habitus does not allow for the use of the cone beam CT machine

    2. Patients whose stones only reside within the mid or distal ureter(s) and thus would not be easily imaged with cone beam CT

    3. Patients who have had lithotripsy on their renal unit within the prior 90 days

    4. Pregnant patients

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Loyola University Medical Center Maywood Illinois United States 60153

    Sponsors and Collaborators

    • Loyola University

    Investigators

    • Principal Investigator: Kristin G Baldea, MD, Attending Physician

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Kristin Baldea, MD, Assistant Professor Of Urology, Loyola University
    ClinicalTrials.gov Identifier:
    NCT04556396
    Other Study ID Numbers:
    • 212740
    First Posted:
    Sep 21, 2020
    Last Update Posted:
    Sep 1, 2021
    Last Verified:
    Aug 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    Yes
    Keywords provided by Kristin Baldea, MD, Assistant Professor Of Urology, Loyola University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Sep 1, 2021